Open AccessComparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry — National Institute of Health
Author(s) -
Joon Ho Ahn,
Ju Yong Hyun,
Myung Ho Jeong,
Ju Han Kim,
Young Joon Hong,
Doo Sun Sim,
Min Chul Kim,
HunSik Park,
Doo-Il Kim,
SeungHo Hur,
Seok Kyu Oh
Publication year - 2021
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2020.0130
Subject(s) - medicine , myocardial infarction , mace , clinical endpoint , cardiology , heart failure , incidence (geometry) , coronary arteries , ace inhibitor , angiotensin converting enzyme , clinical trial , percutaneous coronary intervention , artery , blood pressure , physics , optics
Selecting angiotensin converting enzyme inhibitor (ACEI) or angiotensin II type I receptor blocker (ARB) in patients diagnosed as acute myocardial infarction (AMI) with non-obstructive coronary arteries (MINOCA) is not established. The purpose of this study is to compare the clinical effect of ACEI vs. ARB in MINOCA patients.